AKT1 and metabolic dysfunction-associated steatohepatitis: In addition, α1-NKA signalosome normalization by pNaKtide not only prevents and reverses NASH-related metabolic changes, but its inhibitory effects on the PI3k → Akt pathway picture the signalosome as a tumor suppressor in NASH-related HCC.